David Watson

(Mr. David Watson)

Currently holds a position at Apellis Pharmaceuticals Inc

Positions
Position Company Period
General Counsel, Vice President of Corporate Development Apellis Pharmaceuticals Inc Jan. 1, 2014 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2024-02-13 2024-02-12
S Sale
781 -0.7%
67.77
52,926 USD
781 -0.7% 67.77 52,926 USD
2024-01-31 2024-01-29
S Sale
906 -0.9%
64.14
58,109 USD
906 -0.9% 64.14 58,109 USD
2024-01-23 2024-01-22
S Sale
4,184 -3.8%
65.00
271,943 USD
4,184 -3.8% 65.00 271,943 USD
2024-01-17 2024-01-16
S Sale
4,240 -3.7%
66.81
283,268 USD
4,240 -3.7% 66.81 283,268 USD
2023-12-20 2023-12-19
S Sale
2,300 -2.5%
57.38
131,980 USD
2,300 -2.5% 57.38 131,980 USD
2023-12-20 2023-12-19
S Sale
1,605 -1.7%
57.00
91,492 USD
1,605 -1.7% 57.00 91,492 USD
2023-07-06 2023-07-03
PS Planned sale
8,510 -9.0%
89.98
765,730 USD
8,510 -9.0% 89.98 765,730 USD
2022-06-23 2022-06-22
S Sale
10,000 -8.0%
44.51
445,140 USD
10,000 -8.0% 44.51 445,140 USD
2022-04-27 2022-04-25
PS Planned sale
5,000 -3.8%
50.00
250,000 USD
5,000 -3.8% 50.00 250,000 USD
2021-12-23 2021-12-22
S Sale
300 -0.3%
48.58
14,573 USD
300 -0.3% 48.58 14,573 USD
2021-12-23 2021-12-22
S Sale
5,097 -4.5%
47.86
243,917 USD
5,097 -4.5% 47.86 243,917 USD
2021-12-23 2021-12-22
S Sale
5,174 -4.7%
47.72
246,883 USD
5,174 -4.7% 47.72 246,883 USD
2020-12-15 2020-12-14
S Sale
200 -0.5%
55.91
11,182 USD
200 -0.5% 55.91 11,182 USD
2020-12-15 2020-12-14
S Sale
900 -2.0%
55.00
49,501 USD
900 -2.0% 55.00 49,501 USD
2020-12-15 2020-12-14
S Sale
900 -2.0%
53.86
48,475 USD
900 -2.0% 53.86 48,475 USD
2020-12-15 2020-12-14
S Sale
1,163 -2.5%
52.73
61,322 USD
1,163 -2.5% 52.73 61,322 USD
2020-12-15 2020-12-14
S Sale
2,526 -5.1%
51.32
129,624 USD
2,526 -5.1% 51.32 129,624 USD
2020-12-15 2020-12-14
S Sale
2,709 -5.2%
50.61
137,094 USD
2,709 -5.2% 50.61 137,094 USD
2020-12-15 2020-12-11
S Sale
9,935 -18.6%
50.00
496,750 USD
9,935 -18.6% 50.00 496,750 USD
2020-02-12 2020-02-10
PS Planned sale
5,000 -12.4%
44.50
222,500 USD
5,000 -12.4% 44.50 222,500 USD
2020-01-28 2020-01-27
PS Planned sale
3,000 -13.6%
40.47
121,401 USD
3,000 -13.6% 40.47 121,401 USD